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DEAR EDITOR, 
  The CCR5 is an important chemockine receptor. The 
gene coding for this protein initially gain attention when a 
variant called CCR532 (due to the occurrence of a 32 base 
pair deletion in its coding region) was associated to 
resistance against HIV infection. Thus, homozigous 
CCR532 individuals were shown to be protected against 
HIV-1 infection and heterozigous individuals presented a 
delay on AIDS development [1, 2]. From this sparkling start, 
the CCR5 gene, and specifically the CCR532 allele, 
become a candidate and a target to several studies intending 
to understand and explore such “beneficial allelic variant”. In 
this way, in 1998 the CCR532 variant was suggested to act 
as a protective factor against the development of rheumatoid 
arthritis (RA) [3] and since then several works were 
published attempting to corroborate or refute this initial idea 
and also attempting to inhibit this chemokine receptor, as a 
therapeutic approach in order to modulate rheumatoid arthitis 
symptons [4-9]. 
  Considering the potential association of this chemockine 
receptor and rheumatoid arthritis, it is tempting to analyze the 
effect of this same genetic variant in other rheumatological 
conditions. Juvenile idiopathic arthritis (JIA), for instance, is the 
most common chronic rheumatic disease of childhood and is 
defined as a chronic inflammatory condition that affects the 
synovial joints of individuals aged up to 16 years and that 
persists for at least six weeks. JIA is of unknown etiology, 
although there is evidence that genetic and immunological 
factors are involved in its development. A recently meta-
analysis, performed by Hinks et al. suggested an association of 
the CCR5 gene with juvenile idiopathic arthritis [10]. Although 
we also believe that CCR5 is an important molecule in JIA, our 
results point to opposite directions. While Hinks et al. affirm 
that the CCR532gene variant is associated with protection 
from developing JIA, our results suggest that this variant is 
associated with the most severe forms of the disease [11]. 
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  As our study was not included in the meta-analysis 
performed by Hinks et al., we believe that some 
considerations should be done in order to not avoid 
important information concerning the involvement of the 
CCR5 molecule in JIA. The reason for the non inclusion of 
our work on the meta-analysis was “significant heterogeneity 
between the studies”. Although we can agree that the 
CCR532 allelic frequency among our control sample was 
low (3.8%) as compared to those on the other three studies 
included at the meta-analysis (10.0% in a cohort from the 
United States [6], 11.5% in a population from Norway [9] 
and 11.4% for the United Kingdom study [10]), the 
frequency of the CCR532 allele among JIA patients was 
quite similar amongst all studies, including ours (9.4, 8.8, 
9.7, and 9.2 respectively). The Brazilian population is 
considered to be highly miscegenated, nevertheless, in our 
sample we only included individuals classified as European-
descendent and from the same geographic region (Rio 
Grande do Sul, the southernmost Brazilian state). Rio 
Grande do Sul is a state where African-derived genetic 
contribution to individuals classified as Euro-descendent is 
restricted, as previously discussed [12]. Also, different works 
have already assessed the CCR532 allelic frequency in the 
South population of Brazil, with frequency values ranging 
from 0.035 to 0.066 [12-16]. The ethnic classification used 
by our group (based on phenotypic characteristics of 
individuals and ethnicity data of parents/grandparents 
reported by the participants) is widely adopted in our 
country. Although we must admit that individuals classified 
as European-derived or African-derived can present a certain 
degree of admixture, a recent study which assessed 
individual interethnic admixture using a 48-insertion-
deletion Ancestry-Informative Marker panel, identified a 
very high level of European contribution (94%) and far 
fewer Native American (5%) and African (1%) genes in a 
sample of 81 European-derived individuals from southern 
Brazil [17]. Therefore, the ethnic classification of the 
individuals in our work as European-descendent is supported 
both by the CCR532allelic frequencies among Southern 
Brazilian populations and by the low degree of admixture in 
this region. 
  The ethnic background of a given population certainly 
interferes in the expression of any given feature. For 
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Norwegian cohort do not supported an association between 
the CCR5Delta32 allele and Norwegian RA or JIA patients. 
Nevertheless, when their data was included in a meta-
analysis, overall results still provide evidence for a role for 
CCR5Delta32 in RA. once again highlighting the importance 
of consider the genetic/ethnic background of the analyzed 
population. 
  Even considering that data should be analyzed in a way 
to minimize the effects of genetic/inter-ethnic diversity, 
other aspects are also relevant to establish the real role of the 
CCR5 molecule on JIA. For instance, in the Brazilian cohort 
it was possible to identify a CCR532 allelic frequency 
gradient that correlated with JIA subtypes classified 
according to the number of affected joints, the presence of 
rheumatoid factor (RF), and the degree of systemic 
inflammation, suggesting a relationship between the absence 
of the CCR5 chemokine receptor and the JIA subtypes with a 
broader inflammatory involvement (namely polyarticular 
RF+ and systemic subtypes). Curiously, the only CCR532 
homozygous patient in this sample had systemic JIA and 
presented severe clinical features. Other works also reported 
severe clinical conditions in CCR532 homozygous JIA 
patients. A CCR532 homozygous JIA individual with a 
severe extended oligoarthritis subtype and a CCR532 
homozygous JIA patient with a destructive systemic disease 
with a polyarticular course were reported by two 
independent groups [18, 19]. All these studies, added to the 
fact that six patients on the study from Hinks et al. were also 
CCR532 homozygous indicate that the absence of a 
functional CCR5 molecule does not prevent JIA 
development. Actually, the absence of a functional CCR5 
molecule was already associated with deleterious symptoms, 
or negative outcomes, in several different inflammatory and 
infectious diseases and even with cancer development (see 
review [20]). 
  In JIA, the importance of the CCR5 molecule is 
highlighted not only by its pro-inflammatory role, but also 
by its involvement as a regulatory molecule [21, 22]. It is 
worth mentioning that the level of CCR5 expression (or the 
absence of such expression), as well as the co-expression of 
other chemokine receptors, can influence the migration 
pattern of proinflammatory T cells into the synovium and 
thus the susceptibility to JIA, as previously suggested [23, 
24]. These two works have reported the involvement of the 
CCR5 molecule in the T cell memory compartment of JIA 
patients, at the level of both T cell memory recruitment and 
differentiation. They also suggested that CCR5 expression 
differently affects migration and accumulation of T cells at 
the inflammation site. Specifically, it was observed, when 
analyzing CD27+ memory T cells in the synovium fluid of 
JIA patients, that such cell subpopulation expressed CCR7 
more highly than CCR5 and that a differential pattern of 
CCR5 expression among CD27- and CD27+ memory cells 
was associated to different migratory properties of these 
memory cells into and within the synovial tissue [24]. 
  The CCR5 knockout mouse model provides interesting 
data concerning the effects of the lack of CCR5 expression 
on T cell migration. Although these CCR5 knockout mice 
apparently have a normal immune system, when they are 
infected with a mouse-adapted strain of influenza-A virus 
they display increased mortality rates associated with acute, 
severe pneumonitis, due to altered patterns of immune cell 
migration in and out of the infected lungs [25]. Thus, the 
absence of a functional CCR5 molecule affects several 
different T cell subpopulations, including memory and 
regulatory cells, and can, direct or indirectly, not only impair 
the establishment of immune responses but also interfere on 
the balance of the immune system, allowing the 
establishment of exacerbated inflammatory responses. 
  Juvenile Idiopathic Arthritis is a complex disease, 
characterized by the existence of a number of subtypes 
correlated to different clinical features. Taking together, all 
data from the literature indicates that JIA individuals with 
different disease subtypes will be distinctly affected by the 
absence, or by a lower expression, of the CCR5 molecule. 
Therefore, it will be quite important not only to consider all 
the studies approaching human populations as a whole, but 
also to analyze specific subgroups of individuals, i.e. 
affected by certain JIA subtypes, with specific disease 
courses and so on. In conclusion, in JIA, the CCR532 allele 
seems to be much more a disease modifying factor than a 
susceptibility factor and should, therefore, be analyzed under 
this perspective. We believe that the absence or the reduced 
expression of a functional CCR5 molecule on JIA patients 
provokes a dysregulated pro-inflammatory response on such 
individuals. More studies on the genetics and expression of 
this molecule in different human populations should be 
performed in order to clearly identify the involvement of the 
CCR5 molecule in JIA and in other rheumatologic 
conditions as well as the potential consequences of anti-
CCR5 therapies. 
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ABBREVIATIONS 
CCR5  =  Chemockine receptor gene 5 
JIA  =  Juvenile idiopathic arthritis 
RA =  Rheumatoid  arthritis 
RF =  Rheumatoid  factor 
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